Canopy Growth/$CGC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Canopy Growth
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
- Ticker
- $CGC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 1,128
- Headquarters
- Smiths Falls, Canada
- Website
- www.canopygrowth.com
Canopy Growth Metrics
BasicAdvanced
$250M
-
-$0.49
-
-
Price and volume
Market cap
$250M
52-week high
$2.38
52-week low
$0.58
Average daily volume
2.7M
Financial strength
Current ratio
2.818
Quick ratio
2.092
Long term debt to equity
0.312
Total debt to equity
0.378
Interest coverage (TTM)
-3.58%
Profitability
EBITDA (TTM)
-22.863
Gross margin (TTM)
27.63%
Net profit margin (TTM)
-88.12%
Operating margin (TTM)
-22.84%
Effective tax rate (TTM)
0.52%
Revenue per employee (TTM)
$190,150
Management effectiveness
Return on assets (TTM)
-4.14%
Return on equity (TTM)
-39.19%
Valuation
Price to revenue (TTM)
1.074
Price to book
0.55
Price to tangible book (TTM)
0.7
Price to free cash flow (TTM)
-4.051
Free cash flow yield (TTM)
-24.69%
Free cash flow per share (TTM)
-0.146
Growth
Revenue change (TTM)
10.67%
Earnings per share change (TTM)
-58.23%
3-year revenue growth (CAGR)
1.04%
10-year revenue growth (CAGR)
29.08%
3-year earnings per share growth (CAGR)
-68.54%
10-year earnings per share growth (CAGR)
-0.39%
What the Analysts think about Canopy Growth
Analyst ratings (Buy, Hold, Sell) for Canopy Growth stock.
Analyst projections of the future price of Canopy Growth stock.
Canopy Growth Financial Performance
Revenues and expenses
Canopy Growth Earnings Performance
Company profitability
Upcoming events
No upcoming events
Canopy Growth News
AllArticlesVideos
Canopy Growth Q2 Earnings Call Highlights
MarketBeat5 days ago
Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
Business Wire5 days ago
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Business Wire2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.